Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -60.069% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCCn1c2ccccc2c2cnn(CC(=O)NCCN(C)C)c(=O)c21
[b] Fc1ccccc1-c1nc(-c2ccc(Cl)cc2)no1
[c] COc1ccc2nc(NC(=O)c3cccnc3SC)sc2c1
Answer: a. CCCn1c2ccccc2c2cnn(CC(=O)NCCN(C)C)c(=O)c21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c2ccccc2c2cnn(CC(=O)NCCN(C)C)c(=O)c21
CCCn1c2ccccc2c2cnn(CC(=O)NCCN(C)C)c(=O)c21
N-[2-(dimethylamino)ethyl]-2-(4-oxo-5-propylpyridazino[4,5-b]indol-3-yl)acetamide